Literature DB >> 10079377

p53 and p16INK4A mutations during the progression of glomus tumor.

S Güran1, E T Tali.   

Abstract

Glomus tumors are significantly rare tumors of carotid body. The great majority of these tumors are benign in character. Here we present two brothers with hereditary glomus jugulare tumor who had consanguineous parents. Radiotherapy was applied approximately 8 and 10 years ago for treatment in both cases. Eight years later, one of these cases came to our notice due to relapse. The mutation pattern of p53, p57KIP2, p16INK4A and p15NK4B genes which have roles in the cell cycle, was analyzed in tumor samples obtained from the two affected cases in the initial phase and from one of these cases at relapse. The DNA sample obtained from the case in initial diagnosis phase revealed no p53, p57KIP2, p16INK4A or p15INK4B mutation. He is still in remission phase. Despite the lack of p53, p57KIP2, p16INK4A and p15INK4B mutation at initial diagnosis the tumor DNA of the other case in relapse revealed p53 codon 243 (ATG-->ATC; met-->ile) and p16 codon 97 (GAC-->AAC; asp-->asn) missense point mutations. No loss of heterozygosity in p53 and p16INK4A was observed by microsatellite analysis of tumoral tissues in these cases. P53 and p16INK4A mutations observed in relapse phase were in conserved regions of both genes. No previous reports have been published with these mutations in glomus tumor during progression. The mutation observed in this case may due to radiotherapy. In spite of this possibility, the missense point mutations in conserved region of p53 and p16INK4A genes may indicate the role of p53 and p16INK4A in tumor progression of glomus tumors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10079377     DOI: 10.1053/paor.1999.0041

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  36 in total

1.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

Authors:  M Orita; Y Suzuki; T Sekiya; K Hayashi
Journal:  Genomics       Date:  1989-11       Impact factor: 5.736

2.  Low frequency of p57KIP2 mutation in Beckwith-Wiedemann syndrome.

Authors:  M P Lee; M DeBaun; G Randhawa; B A Reichard; S J Elledge; A P Feinberg
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

3.  Dinucleotide repeat polymorphism at the IFNA locus (9p22).

Authors:  D J Kwiatkowski; M O Diaz
Journal:  Hum Mol Genet       Date:  1992-11       Impact factor: 6.150

4.  Frequent allelic losses of 9p21 markers and low incidence of mutations at p16(CDKN2) gene in non-Hodgkin lymphomas of B-cell lineage.

Authors:  J Fernández-Piqueras; J Santos; I Pérez de Castro; B Meléndez; B Martínez; M Robledo; C Rivas; J Benítez
Journal:  Cancer Genet Cytogenet       Date:  1997-10-01

5.  Polymerase chain reaction detection of a highly polymorphic VNTR segment in intron 1 of the human p53 gene.

Authors:  M Hahn; J Serth; R Fislage; H Wolfes; E Allhoff; V Jonas; A Pingoud
Journal:  Clin Chem       Date:  1993-03       Impact factor: 8.327

Review 6.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

7.  Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution.

Authors:  M H Lee; I Reynisdóttir; J Massagué
Journal:  Genes Dev       Date:  1995-03-15       Impact factor: 11.361

8.  Malignant glomus tumor. A case report of widespread metastases in a patient with multiple glomus body hamartomas.

Authors:  C D Brathwaite; R J Poppiti
Journal:  Am J Surg Pathol       Date:  1996-02       Impact factor: 6.394

9.  Cancer-associated mis-sense and deletion mutations impair p16INK4 CDK inhibitory activity.

Authors:  R Lilischkis; B Sarcevic; C Kennedy; A Warlters; R L Sutherland
Journal:  Int J Cancer       Date:  1996-04-10       Impact factor: 7.396

10.  Germline p16INK4A mutation and protein dysfunction in a family with inherited melanoma.

Authors:  L Liu; N J Lassam; J M Slingerland; D Bailey; D Cole; R Jenkins; D Hogg
Journal:  Oncogene       Date:  1995-07-20       Impact factor: 9.867

View more
  1 in total

Review 1.  Molecular genetic alterations in adrenal and extra-adrenal pheochromocytomas and paragangliomas.

Authors:  Hilde Dannenberg; Paul Komminoth; Winand N M Dinjens; Ernst Jan M Speel; Ronald R de Krijger
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.